ScholarLens Back to search
2012•Science-Business eXchangeOpen access

Fibroblast growth factor receptor 1 ( FGFR1 ; CD331 ), FGFR2 and fibroblast growth factor 19 ( FGF19 ) amplification may help predict sensitivity to FGFR inhibitors in cancer

Author information unavailable

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Fibroblast growth factor receptor, Fibroblast growth factor receptor 1, Fibroblast growth factor, Fibroblast growth factor receptor 4, Fibroblast growth factor receptor 2, Fibroblast growth factor receptor 3, Fibroblast growth factor 23, Cancer research

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Fibroblast growth factor receptor 1 ( FGFR1 ; CD331 ), FGFR2 and fibroblast growth factor 19 ( FGF19 ) amplification may help predict sensitivity to FGFR inhibitors in cancer — Research Paper | ScholarLens